Clinical Proteomics of Biofluids in Haematological Malignancies

Since the emergence of high-throughput proteomic techniques and advances in clinical technologies, there has been a steady rise in the number of cancer-associated diagnostic, prognostic, and predictive biomarkers being identified and translated into clinical use. The characterisation of biofluids ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunphy, Katie, O’Mahoney, Kelly, Dowling, Paul, O’Gorman, Peter, Bazou, Despina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348619/
https://www.ncbi.nlm.nih.gov/pubmed/34360786
http://dx.doi.org/10.3390/ijms22158021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348619/
https://www.ncbi.nlm.nih.gov/pubmed/34360786
http://dx.doi.org/10.3390/ijms22158021

Ejemplares similares